Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study
2012-01-01 Fiorino, G; Biroulet, L; Naccarato, P; De Cassan, C; Bonifacio, C; Sociale, O; Balzarini, L; Repici, A; Malesci, A; Danese, S
A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT
2017-01-01 Armuzzi, A; Fiorino, G; Variola, A; Manetti, N; Fries, W; Rizzuto, G; Bossa, F; Cappello, M; Biancone, L; D'Inca, R; Cantoro, L; Castiglione, F; Principi, M; Annunziata, Ml; Di Girolamo, M; Terpin, Mm; Cortelezzi, Cc; Costa, F; Amato, A; Di Sabatino, A; Saibeni, S; Meucci, G; Petruzzellis, C; Tari, R; Guglielmi, Fw; Guidi, L; Danese, S; Rogai, F; Geccherle, A; Ventra, A; Orlando, A; Andriulli, A; Scrivo, B; Troncone, E; Caccaro, R; Kohn, A; Nardone, Om; Pugliese, D; Annese, V
VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE
2019-01-01 D'Haens, Gr; Cabrijan, Z; Eberhardson, M; van den Berg, Rm; Lowenberg, M; Danese, S; Fiorino, G; Levine, Ya; Chernoff, Dn
The VEGF-VEGF receptor (VEGF-R) pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (IBD)
2006-01-01 Danese, S; Scaldaferri, F; Graziani, C; de la Motte, C; Stigliano, E; Sgambato, A; Ricci, R; Cittadini, A; Gasbarrini, A; Fiocchi, C
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS
2013-01-01 Bosello, Silvia Laura; Bocci, Mario; Poscia, Andrea; Colaiacono, G; La Milia, Daniele Ignazio; De Luca, Giacomo; Berardi, Giorgia; Rucco, Manuela; Correra, Miriam; Canestrari, Giovanni Battista; Capacci, Annunziata; Moscato, Umberto; Ferraccioli, Gianfranco
Marco Bagnoli and Remo Salvadori
2019-01-01 Pola, Francesca
Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria
2020-01-01 Clerici, D; Oltolini, C; Greco, R; Erbella, F; Nitti, R; Ripa, M; Giglio, F; Mastaglio, S; Lorentino, F; Farina, F; Liberatore, C; Castiglioni, B; Din, Ct; Bernardi, M; Peccatori, J; Corti, C; Scarpellini, P; Castagna, A; Ciceri, F
Evaluation of Protective Genetic Variants in HIV-1-infected cART Treated Patients
2018-01-01 Lori, Em; Lepri, Ac; Biasin, M; Mercurio, V; Lo Caputo, S; Castelli, F; Castagna, A; Gori, A; Marchetti, G; Venditti, C; Clerici, M; Monforte, Ad
The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients
2010-01-01 Stellbrink, Hj; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S
Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy
2012-01-01 Cozzi-Lepri, A; Antinori, A; Magistrelli, E; Castelli, F; Rizzardini, G; Castagna, A; Pellizzer, G; Abrescia, N; Parruti, G; Quirino, T; Castelli, P; Vecchiet, J; Monforte, Ad
Cost-effectiveness evaluation of initial HAART regimens for managing HIV-infected patients according to real clinical practice
2012-01-01 Castagna, A; Colombo, G; Salpietro, S; Galli, L; Poli, A; Lazzarin, A
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area
2015-01-01 Gaiera, G; Chiappetta, S; Carbone, A; Ripa, M; Bigoloni, A; Sala, A; Pozzi, T; Bertocchi, I; Galli, L; Ceserani, N; Poli, A; Castagna, A; Lazzarin, A
CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ
2011-01-01 Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S
REAL-LIFE EXPERIENCE OF DAA-BASED REGIMENS PLUS RIBAVIRIN IN CIRRHOTIC PATIENTS COINFECTED WITH HCV AND HIV-1
2016-01-01 Messina, E; Uberti-Foppa, C; Merli, M; Galli, L; Barbanotti, D; Poli, A; Salpietro, S; Morsica, G; Bagaglio, S; Andolina, A; Castagna, A; Lazzarin, A; Hasson, H
Survival in HIV-1 infected individuals with diagnosis of lymphoma compared to general population: data from ICONA Foundation cohort study
2016-01-01 Cingolani, A; Lepri, Ac; Teofili, L; Galli, L; Mazzotta, V; Baldin, Gm; Hohaus, S; Bandera, A; Alba, L; Galizzi, N; Castagna, A; Monforte, Ad; Antinori, A
Changes in patient-reported outcomes during the SENSE Trial: first-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks
2011-01-01 Alvarez, Cm; Clotet, B; Nelson, M; Uglietti, A; Hill, A; van Delft, Y; Marks, S; Castagna, A.
Prescription pattern and determinants of dolutegravir use in an antiretroviral-naive HIV-infected population in Italy: data from the ICONA Foundation cohort study
2016-01-01 Antinori, A; Lepri, Ac; Castagna, A; Lo Caputo, S; Mussini, C; Rusconi, S; Di Biagio, A; Marchetti, G; Nozza, S; Cingolani, A; De Luca, A; Monforte, Ad
PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS
2019-01-01 Clerici, D.; Oltolini, C.; Greco, R.; Pavesi, F.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Lazzari, L.; Scarpellini, P.; Bernardi, M.; Peccatori, J.; Corti, C.; Castagna, A.; Ciceri, F.
PROVIRAL HIV CHANGES CORRELATE WITH CD4+ CD45RA+ T-CELL RECOVERY IN PATIENTS RECEIVING RALTEGRAVIR-INCLUDING REGIMENS
2011-01-01 Gianotti, N.; Malnati, M.; Galli, L.; Galli, A.; Tolazzi, M.; Cassina, G.; Nozza, S.; Della Torre, L.; Castagna, A.; Scarlatti, G.
Patients with HIV-HBV coinfection are an underestimated reservoir for Hepatitis Delta Virus. An analysis of the ICONA cohort
2016-01-01 Gaeta, Gb; Shanyinde, M; Puoti, M; Antonella, Dm; De Luca, A; Castagna, A; Antinori, A; Cozzi-Lepri, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Impact of Medications on Radiologic Disease Activity and Bowel Damage in Crohn's Disease: A Prospective Longitudinal MRI Study | 1-gen-2012 | Fiorino, G; Biroulet, L; Naccarato, P; De Cassan, C; Bonifacio, C; Sociale, O; Balzarini, L; Repici, A; Malesci, A; Danese, S | |
| A PROLONGED FOLLOW-UP ON THE EFFICACY AND SAFETY OF INFLIXIMAB BIOSIMILAR CT-P13 IN IBD ACROSS ITALY: THE PROSIT COHORT | 1-gen-2017 | Armuzzi, A; Fiorino, G; Variola, A; Manetti, N; Fries, W; Rizzuto, G; Bossa, F; Cappello, M; Biancone, L; D'Inca, R; Cantoro, L; Castiglione, F; Principi, M; Annunziata, Ml; Di Girolamo, M; Terpin, Mm; Cortelezzi, Cc; Costa, F; Amato, A; Di Sabatino, A; Saibeni, S; Meucci, G; Petruzzellis, C; Tari, R; Guglielmi, Fw; Guidi, L; Danese, S; Rogai, F; Geccherle, A; Ventra, A; Orlando, A; Andriulli, A; Scrivo, B; Troncone, E; Caccaro, R; Kohn, A; Nardone, Om; Pugliese, D; Annese, V | |
| VAGUS NERVE STIMULATION REDUCES DISEASE ACTIVITY AND MODULATES SERUM AND AUTONOMIC BIOMARKERS IN BIOLOGICREFRACTORY CROHN'S DISEASE | 1-gen-2019 | D'Haens, Gr; Cabrijan, Z; Eberhardson, M; van den Berg, Rm; Lowenberg, M; Danese, S; Fiorino, G; Levine, Ya; Chernoff, Dn | |
| The VEGF-VEGF receptor (VEGF-R) pathway is up-regulated and mediates mucosal angiogenesis in human and experimental inflammatory bowel disease (IBD) | 1-gen-2006 | Danese, S; Scaldaferri, F; Graziani, C; de la Motte, C; Stigliano, E; Sgambato, A; Ricci, R; Cittadini, A; Gasbarrini, A; Fiocchi, C | |
| ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS | 1-gen-2013 | Bosello, Silvia Laura; Bocci, Mario; Poscia, Andrea; Colaiacono, G; La Milia, Daniele Ignazio; De Luca, Giacomo; Berardi, Giorgia; Rucco, Manuela; Correra, Miriam; Canestrari, Giovanni Battista; Capacci, Annunziata; Moscato, Umberto; Ferraccioli, Gianfranco | |
| Marco Bagnoli and Remo Salvadori | 1-gen-2019 | Pola, Francesca | |
| Impact of Levofloxacin for Prophylaxis of Pre-engraftment Bloodstream Infections after Allogeneic HSCT: A single-center Matched Analysis in an Endemic Country for Carbapenem-resistant Gram-negative Bacteria | 1-gen-2020 | Clerici, D; Oltolini, C; Greco, R; Erbella, F; Nitti, R; Ripa, M; Giglio, F; Mastaglio, S; Lorentino, F; Farina, F; Liberatore, C; Castiglioni, B; Din, Ct; Bernardi, M; Peccatori, J; Corti, C; Scarpellini, P; Castagna, A; Ciceri, F | |
| Evaluation of Protective Genetic Variants in HIV-1-infected cART Treated Patients | 1-gen-2018 | Lori, Em; Lepri, Ac; Biasin, M; Mercurio, V; Lo Caputo, S; Castelli, F; Castagna, A; Gori, A; Marchetti, G; Venditti, C; Clerici, M; Monforte, Ad | |
| The SENSE trial: etravirine shows lower prevalence and severity of neuropsychiatric adverse events compared to efavirenz in treatment-naïve patients | 1-gen-2010 | Stellbrink, Hj; Rugina, S; Zagler, C; Esser, S; Castagna, A; Gazzard, B; Hill, A; van Delft, Y; Marks, S | |
| Durability of FTC/TDF-containing cART regimens in a large cohort of HIV-infected patients seen for care in Italy | 1-gen-2012 | Cozzi-Lepri, A; Antinori, A; Magistrelli, E; Castelli, F; Rizzardini, G; Castagna, A; Pellizzer, G; Abrescia, N; Parruti, G; Quirino, T; Castelli, P; Vecchiet, J; Monforte, Ad | |
| Cost-effectiveness evaluation of initial HAART regimens for managing HIV-infected patients according to real clinical practice | 1-gen-2012 | Castagna, A; Colombo, G; Salpietro, S; Galli, L; Poli, A; Lazzarin, A | |
| Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area | 1-gen-2015 | Gaiera, G; Chiappetta, S; Carbone, A; Ripa, M; Bigoloni, A; Sala, A; Pozzi, T; Bertocchi, I; Galli, L; Ceserani, N; Poli, A; Castagna, A; Lazzarin, A | |
| CHANGES IN PATIENT-REPORTED OUTCOMES DURING THE SENSE TRIAL: FIRST-LINE TREATMENT WITH 2 NRTIS PLUS ETRAVIRINE OR EFAVIRENZ | 1-gen-2011 | Castagna, A; Lazzarin, A; Carosi, G; Andreoni, M; Orkin, C; Streinu-Cercel, A; Erscoiu, S; Nelson, M; Hill, A; van Delft, Y; Marks, S | |
| REAL-LIFE EXPERIENCE OF DAA-BASED REGIMENS PLUS RIBAVIRIN IN CIRRHOTIC PATIENTS COINFECTED WITH HCV AND HIV-1 | 1-gen-2016 | Messina, E; Uberti-Foppa, C; Merli, M; Galli, L; Barbanotti, D; Poli, A; Salpietro, S; Morsica, G; Bagaglio, S; Andolina, A; Castagna, A; Lazzarin, A; Hasson, H | |
| Survival in HIV-1 infected individuals with diagnosis of lymphoma compared to general population: data from ICONA Foundation cohort study | 1-gen-2016 | Cingolani, A; Lepri, Ac; Teofili, L; Galli, L; Mazzotta, V; Baldin, Gm; Hohaus, S; Bandera, A; Alba, L; Galizzi, N; Castagna, A; Monforte, Ad; Antinori, A | |
| Changes in patient-reported outcomes during the SENSE Trial: first-line treatment with 2 NRTIs plus etravirine or efavirenz for 48 weeks | 1-gen-2011 | Alvarez, Cm; Clotet, B; Nelson, M; Uglietti, A; Hill, A; van Delft, Y; Marks, S; Castagna, A. | |
| Prescription pattern and determinants of dolutegravir use in an antiretroviral-naive HIV-infected population in Italy: data from the ICONA Foundation cohort study | 1-gen-2016 | Antinori, A; Lepri, Ac; Castagna, A; Lo Caputo, S; Mussini, C; Rusconi, S; Di Biagio, A; Marchetti, G; Nozza, S; Cingolani, A; De Luca, A; Monforte, Ad | |
| PS1268 CEFTAZIDIME/AVIBACTAM AND CEFTOLOZANE/TAZOBACTAM FOR THE TREATMENT OF FEBRILE NEUTROPENIA IN ALLOGENEIC TRANSPLANT RECIPIENTS | 1-gen-2019 | Clerici, D.; Oltolini, C.; Greco, R.; Pavesi, F.; Giglio, F.; Mastaglio, S.; Lorentino, F.; Lazzari, L.; Scarpellini, P.; Bernardi, M.; Peccatori, J.; Corti, C.; Castagna, A.; Ciceri, F. | |
| PROVIRAL HIV CHANGES CORRELATE WITH CD4+ CD45RA+ T-CELL RECOVERY IN PATIENTS RECEIVING RALTEGRAVIR-INCLUDING REGIMENS | 1-gen-2011 | Gianotti, N.; Malnati, M.; Galli, L.; Galli, A.; Tolazzi, M.; Cassina, G.; Nozza, S.; Della Torre, L.; Castagna, A.; Scarlatti, G. | |
| Patients with HIV-HBV coinfection are an underestimated reservoir for Hepatitis Delta Virus. An analysis of the ICONA cohort | 1-gen-2016 | Gaeta, Gb; Shanyinde, M; Puoti, M; Antonella, Dm; De Luca, A; Castagna, A; Antinori, A; Cozzi-Lepri, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista3192
Data di pubblicazione
- In corso di stampa1
- 2020 - 202596
- 2010 - 20191464
- 2000 - 20091294
- 1990 - 1999321
- 1983 - 198916
Editore
- ELSEVIER22
- LIPPINCOTT WILLIAMS & WILKINS14
- NLM (Medline)13
- URBAN & VOGEL12
- ELSEVIER SCIENCE BV11
- DR DIETRICH STEINKOPFF VERLAG10
- ELSEVIER SCIENCE INC10
- OXFORD UNIV PRESS10
- SPRINGER HEIDELBERG10
- SPRINGER9
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS174
- JOURNAL OF NEUROLOGY153
- THE JOURNAL OF UROLOGY152
- BONE MARROW TRANSPLANTATION127
- EUROPEAN NEUROPSYCHOPHARMACOLOGY126
- NEUROLOGICAL SCIENCES88
- BLOOD86
- EUROPEAN HEART JOURNAL72
- NEUROLOGY72
- GASTROENTEROLOGY71
Keyword
- systemic sclerosis12
- Children4
- fibrosis4
- JIA4
- JSLE4
- None4
- angiogenesis3
- animal model3
- Bone mass3
- IPMN3
Lingua
- eng1301
- ita202
- und13
Accesso al fulltext
- no fulltext3161
- reserved25
- open6